ID: ALA5198941

Max Phase: Preclinical

Molecular Formula: C33H50N2O10

Molecular Weight: 634.77

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/[C@H]1O[C@H](CC(=O)NCCC(=O)O)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)C(C)C)C[C@@H]1C

Standard InChI:  InChI=1S/C33H50N2O10/c1-19(2)32(41)43-22(5)9-12-28(36)35-25-15-21(4)26(44-23(25)6)10-7-20(3)8-11-27-31(40)33(18-42-33)17-24(45-27)16-29(37)34-14-13-30(38)39/h7-9,11-12,19,21-27,31,40H,10,13-18H2,1-6H3,(H,34,37)(H,35,36)(H,38,39)/b11-8+,12-9-,20-7+/t21-,22-,23+,24+,25+,26-,27+,31+,33+/m0/s1

Standard InChI Key:  ZPKBORRTDRMIOU-GSSLLIHVSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 634.77Molecular Weight (Monoisotopic): 634.3465AlogP: 2.59#Rotatable Bonds: 14
Polar Surface Area: 173.02Molecular Species: ACIDHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.89CX Basic pKa: CX LogP: 1.95CX LogD: -1.27
Aromatic Rings: 0Heavy Atoms: 45QED Weighted: 0.10Np Likeness Score: 1.92

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source